Related references
Note: Only part of the references are listed.Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible A Transcanadian Study
Martin Koebel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
The Heterogeneity of Epithelial Ovarian Cancer
David M. Gershenson
CANCER (2010)
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
Martin Koebel et al.
JOURNAL OF PATHOLOGY (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pathogenetic Pathways in Ovarian Endometrioid Adenocarcinoma A Molecular Study of 29 Cases
Julia Turbiner Geyer et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Ovarian carcinoma pathology and genetics: recent advances
C. Blake Gilks et al.
HUMAN PATHOLOGY (2009)
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
Judith Hugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
Martin Koebel et al.
MODERN PATHOLOGY (2009)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Implementation of a Canadian External Quality Assurance Program for Breast Cancer Biomarkers An Initiative of Canadian Quality Control in Immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry
Jefferson Terry et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
Martin Köbel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
J. K. Chan et al.
BRITISH JOURNAL OF CANCER (2008)
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
C. Blake Gilks et al.
HUMAN PATHOLOGY (2008)
Mammaglobin B expression in human endometrial cancer
R. A. Tassi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
Leah M. Prentice et al.
BMC MEDICINE (2007)
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F. Hayes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin?
Guo-Xia Tong et al.
MODERN PATHOLOGY (2007)
High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour
C. J. O'Neill et al.
HISTOPATHOLOGY (2007)
Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry
R Nenutil et al.
JOURNAL OF PATHOLOGY (2005)
Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment
V Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
CD44 variant 6 in endometrioid carcinoma of the uterus: Its expression in the adenocarcinoma component is an independent prognostic marker
K Hoshimoto et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia
R Klaes et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: DPc4 assists in identifying metastatic pancreatic carcinomas
HX Ji et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2002)
Share Paper
